✳flâneur — a map of the web's best reading

Semaglutide - Wikipedia

en.wikipedia.org · 14,431 words · saved by 1 readers

Semaglutide is an anti-diabetic medication used for the treatment of type 2 diabetes and an anti-obesity medication used for long-term weight management.[22][23][24] It is a peptide similar to the hormone glucagon-like peptide-1 (GLP-1), modified with a side chain.[25][26] It can be administered by subcutaneous injection or taken orally.[13][14][15][27] It is sold by Novo Nordisk under the brand names Ozempic[13] and Rybelsus[14] for diabetes, and under the brand name Wegovy for weight management and weight loss.[12][15] Semaglutide is a glucagon-like peptide-1 receptor agonist.[13][14][15] The most common side effects include nausea, vomiting, diarrhea, abdominal pain, and constipation.[13][16][17][18][28] It was approved for medical use in the US in 2017.[13][29] In 2022, it was the 48th most commonly prescribed medication in the United States, with more than 13 million prescriptions.[30][31] In the US, semaglutide is indicated as an adjunct to diet and exercise to improve glycemic c

Semaglutide - Wikipedia Jump to content From Wikipedia, the free encyclopedia Anti-diabetic and anti-obesity medication "},"pronounce":{"wt":"{{IPAc-en|s|ɛ|m|ˈ|æ|g|l|ʊ|t|aɪ|d}} {{respell|sem|AG|luu|tyde}} or {{IPAc-en|ˌ|s|ɛ|m|ə|ˈ|g|l|uː|t|aɪ|d|audio=LL-Q1860 (eng)-Naomi Persephone Amethyst (NaomiAmethyst)-semaglutide.wav}} {{respell|SEM|ə|GLOO|tyde}}"},"tradename":{"wt":"Ozempic, Rybelsus, Wegovy, [[#Generics_and_copies|others]]"},"Drugs.com":{"wt":"{{Drugs.com|monograph|semaglutide}}"},"MedlinePlus":{"wt":"a618008"},"DailyMedID":{"wt":"Semaglutide"},"pregnancy_AU":{"wt":"D"},"pregnancy_AU_com

Explore this link on the map →

related reading